ARCHIVES

NCI Criticized For Delays In Development Of New Drugs

This article is from The Cancer Letter archive.

Vol. 01 No. 04 | January 24, 1975

Download PDF Visit The Full Archive

Related Articles

NCI Critics Take Their Best Shots, Seek New Emphasis On Prevention At Kennedy Hearings

March 16, 1979

Educational Strategies On Mammography, Not Guidelines, To Come From NCAB

February 28, 1997

Amgen’s Aranesp Sales Dropped By Half, Continue To Fall.

November 14, 2008

ACS Approves 127 Cancer Programs; Total Now 994

March 18, 1983

Dingell Asks FDA To Explain Failure To Curtail ESA Ads.

June 15, 2007

Anticancer Vaccine Trials Due In Three-Four Years; Virus Research Opportunities Described

July 25, 1975